Header

UZH-Logo

Maintenance Infos

Effect of Supplemental Oxygen on Blood Pressure in Obstructive Sleep Apnea (SOX): A Randomised, CPAP Withdrawal Trial


Turnbull, Chris D; Sen, Dushendree; Kohler, Malcolm; Petousi, Nayia; Stradling, John R (2018). Effect of Supplemental Oxygen on Blood Pressure in Obstructive Sleep Apnea (SOX): A Randomised, CPAP Withdrawal Trial. American Journal of Respiratory and Critical Care Medicine:0240OC.

Abstract

Rationale: Obstructive sleep apnoea (OSA) is associated with systemic hypertension. Either overnight intermittent hypoxia, or the recurrent arousals that occur in OSA, could cause the daytime increases in blood pressure (BP). Objectives: To establish the role of intermittent hypoxia in the increased morning BP in patients with OSA. Methods: Randomised, double-blinded, cross-over trial assessing the effects of overnight supplemental oxygen versus air (sham) on morning BP, following continuous positive airway pressure (CPAP) withdrawal in patients with moderate to severe OSA. The primary outcome was the change in home morning BP following CPAP withdrawal for 14 nights, oxygen versus air. Secondary outcomes included oxygen desaturation index (ODI), apnoea hypopnoea index (AHI), subjective (Epworth sleepiness score) and objective (Oxford sleep resistance test) sleepiness. Measurements and main results: Supplemental oxygen virtually abolished the BP rise following CPAP withdrawal and, compared to air, significantly reduced the rise in mean systolic BP (-6.6mmHg; 95% confidence interval or CI -11.3 to -1.9; p=0.008), mean diastolic BP (-4.6mmHg; 95% CI -7.8 to -1.5; p=0.006), and median ODI (-23.8/h; interquartile range -31.0, -16.3; p<0.001), following CPAP withdrawal. There was no significant difference, oxygen versus air, in AHI, subjective or objective sleepiness. Conclusions: Supplemental oxygen virtually abolished the rise in morning BP during CPAP withdrawal. Supplemental oxygen substantially reduced intermittent hypoxia, but had a minimal effect on markers of arousal (including AHI), subjective or objective sleepiness. Therefore intermittent hypoxia, and not recurrent arousals, appears to be the dominant cause of daytime increases in BP in OSA. Clinical trial registration available at www.isrctn.com, ID ISRCTN 17987510.
Keywords: sleep apnea, obstructive; blood pressure; intermittent hypoxia

Abstract

Rationale: Obstructive sleep apnoea (OSA) is associated with systemic hypertension. Either overnight intermittent hypoxia, or the recurrent arousals that occur in OSA, could cause the daytime increases in blood pressure (BP). Objectives: To establish the role of intermittent hypoxia in the increased morning BP in patients with OSA. Methods: Randomised, double-blinded, cross-over trial assessing the effects of overnight supplemental oxygen versus air (sham) on morning BP, following continuous positive airway pressure (CPAP) withdrawal in patients with moderate to severe OSA. The primary outcome was the change in home morning BP following CPAP withdrawal for 14 nights, oxygen versus air. Secondary outcomes included oxygen desaturation index (ODI), apnoea hypopnoea index (AHI), subjective (Epworth sleepiness score) and objective (Oxford sleep resistance test) sleepiness. Measurements and main results: Supplemental oxygen virtually abolished the BP rise following CPAP withdrawal and, compared to air, significantly reduced the rise in mean systolic BP (-6.6mmHg; 95% confidence interval or CI -11.3 to -1.9; p=0.008), mean diastolic BP (-4.6mmHg; 95% CI -7.8 to -1.5; p=0.006), and median ODI (-23.8/h; interquartile range -31.0, -16.3; p<0.001), following CPAP withdrawal. There was no significant difference, oxygen versus air, in AHI, subjective or objective sleepiness. Conclusions: Supplemental oxygen virtually abolished the rise in morning BP during CPAP withdrawal. Supplemental oxygen substantially reduced intermittent hypoxia, but had a minimal effect on markers of arousal (including AHI), subjective or objective sleepiness. Therefore intermittent hypoxia, and not recurrent arousals, appears to be the dominant cause of daytime increases in BP in OSA. Clinical trial registration available at www.isrctn.com, ID ISRCTN 17987510.
Keywords: sleep apnea, obstructive; blood pressure; intermittent hypoxia

Statistics

Citations

Dimensions.ai Metrics

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Pneumology
Dewey Decimal Classification:610 Medicine & health
Uncontrolled Keywords:Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine
Language:English
Date:20 July 2018
Deposited On:04 Jan 2019 10:03
Last Modified:04 Jan 2019 10:13
Publisher:American Thoracic Society
ISSN:1073-449X
OA Status:Closed
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1164/rccm.201802-0240oc
PubMed ID:30025470

Download

Full text not available from this repository.
View at publisher

Get full-text in a library